Skip to main content
  • The CBI chevron_right
  • Can the R&D process for vaccines become a blueprint for innovation?

Can the R&D process for vaccines become a blueprint for innovation?

Njy Rios Innovation Incentives Director at Ayming UK

COVID-19 has forced us to innovate with unparalleled urgency – what would happen if we channelled that energy into addressing climate change?

07 Dec 2020, 6 min read

Exclusive member-only content Already a member?

Exclusive member-only content
error_outline
This should be your company email address
visibility_off

Not a member yet?

Every member matters.
Whatever and wherever your business, no matter how big or small, you can benefit by being a CBI member. With offices, events, and services across the UK, we're here to support you.

Find out more